Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-CPB2 (310-410) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:200-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CPB2 |
Gene ID: |
1361 |
Uniprot ID: |
CBPB2_HUMAN |
Immunogen Region: |
310-410 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 310-410 of human CPB2 (NP_001863.3). |
Immunogen Sequence: |
HSYSQHIVFPYSYTRSKSKD HEELSLVASEAVRAIEKISK NTRYTHGHGSETLYLAPGGG DDWIYDLGIKYSFTIELRDT GTYGFLLPERYIKPTCREAF A |
Tissue Specificity | Plasma.synthesized in the liver. |
Post Translational Modifications | N-glycosylated. N-glycan at Asn-108: Hex5HexNAc4. |
Function | Cleaves C-terminal arginine or lysine residues from biologically active peptides such as kinins or anaphylatoxins in the circulation thereby regulating their activities. Down-regulates fibrinolysis by removing C-terminal lysine residues from fibrin that has already been partially degraded by plasmin. |
Protein Name | Carboxypeptidase B2Carboxypeptidase UCpuPlasma Carboxypeptidase BPcpbThrombin-Activable Fibrinolysis InhibitorTafi |
Database Links | Reactome: R-HSA-2022377Reactome: R-HSA-977606 |
Cellular Localisation | Secreted |
Alternative Antibody Names | Anti-Carboxypeptidase B2 antibodyAnti-Carboxypeptidase U antibodyAnti-Cpu antibodyAnti-Plasma Carboxypeptidase B antibodyAnti-Pcpb antibodyAnti-Thrombin-Activable Fibrinolysis Inhibitor antibodyAnti-Tafi antibodyAnti-CPB2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance